Spero Therapeutics, Inc.
SPRO
$2.64
-$0.14-5.04%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 40.27M | 48.62M | 31.19M | 48.89M | 52.89M |
| Total Receivables | 25.39M | 2.46M | 26.91M | 24.28M | 52.48M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.63M | 1.25M | 1.30M | 1.55M | 1.91M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 67.29M | 52.32M | 59.40M | 74.71M | 107.28M |
|
|
|||||
| Total Current Assets | 67.29M | 52.32M | 59.40M | 74.71M | 107.28M |
| Net Property, Plant & Equipment | 1.48M | 1.69M | 2.56M | 2.84M | 3.11M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 153.00K | 153.00K | 153.00K | 153.00K | 153.00K |
| Total Assets | 68.92M | 54.17M | 62.12M | 77.71M | 110.54M |
|
|
|||||
| Total Accounts Payable | 693.00K | 1.40M | 780.00K | 1.77M | 7.31M |
| Total Accrued Expenses | 5.58M | 7.81M | 6.64M | 8.05M | 17.27M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.96M | 1.90M | 1.84M | 1.80M | 1.75M |
| Total Finance Division Other Current Liabilities | 641.00K | 2.55M | 5.68M | 17.55M | 22.75M |
| Total Other Current Liabilities | 641.00K | 2.55M | 5.68M | 17.55M | 22.75M |
| Total Current Liabilities | 8.87M | 13.65M | 14.95M | 29.16M | 49.07M |
|
|
|||||
| Total Current Liabilities | 8.87M | 13.65M | 14.95M | 29.16M | 49.07M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 939.00K | 1.45M | 1.77M | 2.17M | 2.55M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 91.00K | 12.58M | 12.58M | 12.58M | 12.80M |
| Total Liabilities | 9.90M | 27.68M | 29.29M | 43.90M | 64.42M |
|
|
|||||
| Common Stock & APIC | 510.09M | 509.08M | 508.03M | 507.32M | 505.76M |
| Retained Earnings | -451.07M | -482.59M | -475.20M | -473.50M | -459.64M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 59.02M | 26.49M | 32.83M | 33.81M | 46.12M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 59.02M | 26.49M | 32.83M | 33.81M | 46.12M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 59.02M | 26.49M | 32.83M | 33.81M | 46.12M |
|
|
|||||